Page last updated: 2024-10-28

hypericin and Hepatitis C

hypericin has been researched along with Hepatitis C in 2 studies

Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.

Research Excerpts

ExcerptRelevanceReference
"Hypericin has potent activity against HIV and other viruses, is compatible with anticoagulants used to store blood, and does not affect blood chemistry when stored for 21 days."3.69Hypericin: an answer for safer blood? ( Kuhn, D, 1995)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furuta, A1
Tsubuki, M1
Endoh, M1
Miyamoto, T1
Tanaka, J1
Salam, KA1
Akimitsu, N1
Tani, H1
Yamashita, A1
Moriishi, K1
Nakakoshi, M1
Sekiguchi, Y1
Tsuneda, S1
Noda, N1
Kuhn, D1

Other Studies

2 other studies available for hypericin and Hepatitis C

ArticleYear
Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase.
    International journal of molecular sciences, 2015, Aug-07, Volume: 16, Issue:8

    Topics: Anthracenes; Anthraquinones; Antiviral Agents; Cell Line; Hepacivirus; Hepatitis C; Humans; Perylene

2015
Hypericin: an answer for safer blood?
    Common factor (Stoughton, Mass.), 1995, Issue:no 10

    Topics: Anthracenes; Antiviral Agents; Blood Preservation; Blood-Borne Pathogens; Clinical Trials as Topic;

1995